Eisai
4523.T
#1940
Rank
S$11.39 B
Marketcap
$40.44
Share price
-0.11%
Change (1 day)
-36.49%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.95. In 2022 the company made an earnings per share (EPS) of $2.16 a decrease over its 2021 EPS that were of $9.60.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9636.91%
2022$2.16-77.48%
2021$9.60-41.88%
2020$16.51-0.94%
2019$16.6752.59%
2018$10.93124.17%
2017$4.87-49.42%
2016$9.6437.08%
2015$7.03-11.75%
2014$7.97-3.23%
2013$8.23-18.56%
2012$10.11-15.51%
2011$11.96-3.75%
2010$12.43-1.36%
2009$12.60